Skip to main content
main-content

Devices and technology: Continuous glucose monitoring

medwireNews

09-25-2019 | Hypoglycemia | EASD 2019 | News

Daytime hyperglycemia, nocturnal hypoglycemia remain problems for EDIC cohort

People with type 1 diabetes rarely achieve the current targets for blood glucose control, with nocturnal hypoglycemia remaining a particular concern, shows an analysis of the DCCT/EDIC cohort.

09-19-2019 | Continuous glucose monitoring | EASD 2019 | News

Majority of MDI users improve glycemic outcomes with CGM

Analysis of the GOLD study suggests that at least three-quarters of people with type 1 diabetes using multiple daily injections benefit from continuous glucose monitoring.

09-17-2019 | Continuous glucose monitoring | EASD 2019 | News

CGM benefits persist with long-term use

The COMISAIR-2 researchers have reported that use of continuous glucose monitoring by people with type 1 diabetes remains high over 3 years, resulting in continued glycemic benefits.

08-27-2019 | Insulin pumps | News

Predictive low-glucose insulin suspend system cuts hypoglycemia in real world

Switching to a predictive low-glucose suspend insulin delivery system significantly reduces hypoglycemia risk in people with diabetes in clinical practice, research shows.

08-08-2019 | Continuous glucose monitoring | News

Pros and cons of CGM described by parents of children with diabetes

Continuous glucose monitoring offers many benefits to the families of young children with type 1 diabetes but also a number of challenges that cannot always be overcome, show results of a qualitative analysis conducted in the USA.

07-12-2019 | Continuous glucose monitoring | Highlight | News

CGM measures have variable correlation with HbA1c

Glycated hemoglobin levels correlate strongly with continuous glucose monitoring-measured average blood glucose and hyperglycemia, but poorly with hypoglycemia, say researchers.

07-05-2019 | Continuous glucose monitoring | News

ATTD consensus group releases time in range recommendations

A statement from an ATTD consensus group has streamlined previously agreed continuous glucose monitoring metrics and set out time in range targets.

06-11-2019 | Hypoglycemia | ADA 2019 | News

CGM data can predict future severe hypoglycemia

Most hypoglycemia outcomes measured by real-time continuous glucose monitoring can be used to predict future severe hypoglycemia in people with type 1 diabetes, with similar levels of accuracy, study findings indicate.

05-29-2019 | Insulin pumps | News

Real-world data confirm benefits of ‘pump-suspend’ technology in diabetes

Exposure to hypoglycemia deceases significantly with increasing levels of insulin suspension automation in people with type 1 diabetes, real‐world study data show.

05-23-2019 | Type 1 diabetes | News

Treatment simplification a major unmet need in type 1 diabetes

People with type 1 diabetes have high-priority concerns that go beyond glucose control, including complex and mentally taxing treatment and weight gain, report researchers.

05-20-2019 | Continuous glucose monitoring | News

CGM still lags behind SMBG during aerobic exercise

Even with newer devices, continuous glucose monitoring underestimates the fall in glucose levels during exercise, with the drop lagging significantly behind that measured by self-monitoring of blood glucose, research shows.

05-01-2019 | Hypoglycemia | News

Hypoglycemia-prone adults benefit from suspend-before-low pump technology

People with type 1 diabetes at high hypoglycemia risk using insulin pumps have fewer hypoglycemic events if the pump is linked to a continuous glucose monitor and has a suspend-before-low feature, SMILE study data show.

04-03-2019 | Continuous glucose monitoring | News

Real-world data support predictive low-glucose alerts for hypoglycemia avoidance

The frequency at which people with type 1 diabetes experience hypoglycemia decreases during the first 30 days after they switch to a continuous glucose monitor that incorporates a predictive low-glucose alert, research shows.

03-25-2019 | Hypoglycemia | News

Problem of hypoglycemia unawareness highlighted in older people with type 1 diabetes

Baseline data from the WISDM trial show that older adults with type 1 diabetes who have impaired awareness of hypoglycemia symptoms can spend over half an hour per day with extremely low blood glucose levels.

03-08-2019 | Pregnancy | DUKPC 2019 | News

CONCEPTT data show substantial cost savings with CGM in pregnancy

Using continuous glucose monitoring for all women with type 1 diabetes during pregnancy could save the UK National Health Service over 9 million pounds per year, report the CONCEPTT investigators.

02-26-2019 | Psychosocial care | ATTD 2019 | News

CGM at diabetes diagnosis improves family psychosocial outcomes

Giving children continuous glucose monitoring from the point of diabetes diagnosis gives their caregivers greater confidence to manage hypoglycemia and reduces their diabetes-related distress, shows a randomized trial.

02-15-2019 | Patient-reported outcomes | News

Gap between glycemic, patient-reported outcomes in HypoDE study

Continuous glucose monitoring has a less impressive effect on patient-reported outcomes than on glycemic control among patients with type 1 diabetes, reveal the HypoDE investigators.

02-01-2019 | Artificial pancreas systems | News

Support for hybrid closed-loop insulin delivery in young children

Home use of day and night hybrid closed-loop insulin delivery using the Cambridge model predictive control algorithm is feasible in children aged 1–7 years with type 1 diabetes, researchers report.

11-07-2018 | Pregnancy | News

Surprising CONCEPTT findings on insulin pumps versus injections in pregnant women

A prespecified analysis of the CONCEPTT trial shows that pregnant women with type 1 diabetes who were using pumps at baseline did not achieve as good glycemic control as those using multiple daily injections.

08-22-2018 | Insulin pumps | News

Predictive insulin-suspend algorithm cuts hypoglycemia without consequent hyperglycemia

The Tandem Basal-IQ predictive low-glucose suspend insulin delivery system significantly reduces the proportion of time adults and children spend in hypoglycemia during 24-hour usage, show findings from the randomized crossover PROLOG trial.

Image Credits